| Brenda Beverly Hunter, MA | |
|
2831 Riva Ridge Cir, Cottage Grove, WI 53527-9549 | |
| (608) 630-5346 | |
| Not Available |
| Full Name | Brenda Beverly Hunter |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 2831 Riva Ridge Cir, Cottage Grove, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962410092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 4164-125 (Wisconsin) | Primary |
| 101YP2500X | Counselor - Professional | 180003943 (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Beverly Hunter, MA 2831 Riva Ridge Cir, Cottage Grove, WI 53527-9549 Ph: (608) 630-5346 | Brenda Beverly Hunter, MA 2831 Riva Ridge Cir, Cottage Grove, WI 53527-9549 Ph: (608) 630-5346 |
News Archive
Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.
The first MRI scan to show 'brown fat' in a living adult could prove to be an essential step towards a new wave of therapies to aid the fight against diabetes and obesity.
Researchers from the Department of Orthopedics of Tongji Hospital at Tongji University in Shanghai have successfully used a nanobiomaterial called layered double hydroxide (LDH) to inhibit the inflammatory environment surrounding spinal cord injuries in mice, accelerating regeneration of neurons and reconstruction of the neural circuit in the spine.
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced today that it has signed a statement of intent with the World Health Organization to supply free of charge a primary medicine for the treatment of lymphatic filariasis.
Children and adolescents who take medication for attention-deficit hyperactivity disorder (ADHD) show decreased bone density, according to a large cross-sectional study presented today at the 2016 Annual Meeting of the American Academy of Orthopaedic Surgeons.
› Verified 8 days ago
Ms. Ann M Goedken, MS, LCSW,LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 747b Crawford Dr, Cottage Grove, WI 53527 Phone: 608-839-1979 |